P4HB and deep vein thrombosis: Significantly less GRP94 immunostaining in thrombi is observed in the DVT and PDI inhibitor group and the DVT and GRP94 inhibitor group (p < 0.001, Supplementary Figure S5H,I) than in the DVT group.